TYR and nervous system disorder: Taken together, this is the first report about successful application of NeuroD1-mediated AtN conversion technology in NHP models, which might fill some gaps between in vivo rodent models and in vitro human astrocyte culture models, as well as take an important step toward future clinical trials using such technology for nervous system diseases with neuronal loss.